-
Symbol
-
ALNY on Nasdaq
-
Investment type
-
Equity / COMMON STOCK
-
Latest Disclosed Shares Owned
-
6,968,513 shares
-
Security Ownership %
-
5.4%
Shares, Excluding Options vs Price
Capital Research Global Investors ownership in ALNYLAM PHARMACEUTICALS, INC. COMMON STOCK (ALNY)
13 Feb 2025 - Capital Research Global Investors has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,968,513 shares of ALNYLAM PHARMACEUTICALS, INC. COMMON STOCK (ALNY).
This represents 5.4% ownership of the company.
This is the first filing by Capital Research Global Investors disclosing ownership of ALNYLAM PHARMACEUTICALS, INC. COMMON STOCK (ALNY).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.